SK-II’s latest research into skin ageing has revealed data that it claims enhances the relevance of its hero ingredient, PITERA, to a younger demographic of skin care consumers.
The multinational is collaborating with the German Cancer Research Centre (DKFZ) in a €4.8m research facility to find a way to prevent the skin disease.
A Japanese skin care brand specialising in developing products with nicotinamide mononucleotide (NMN) is gearing up to expand overseas for the first time, beginning with Singapore.